Experience of measuring nasal nitric oxide (nNO) in a National Primary Ciliary Dyskinesia (PCD) Centre (2006-20)
A. Harris (Southampton (Hampshire), United Kingdom), H. Phan (Southampton (Hampshire), United Kingdom), F. Borca (Southampton (Hampshire), United Kingdom), S. Packham (Southampton (Hampshire), United Kingdom), A. Friend (Southampton (Hampshire), United Kingdom), H. Wilkins (Southampton (Hampshire), United Kingdom), A. Glen (Southampton (Hampshire), United Kingdom), W. Walker (Southampton (Hampshire), United Kingdom), J. Lucas (Southampton (Hampshire), United Kingdom)
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Session: Mechanism or pathways of chronic lung diseases
Session type: E-poster session
Number: 2070
Disease area: Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Harris (Southampton (Hampshire), United Kingdom), H. Phan (Southampton (Hampshire), United Kingdom), F. Borca (Southampton (Hampshire), United Kingdom), S. Packham (Southampton (Hampshire), United Kingdom), A. Friend (Southampton (Hampshire), United Kingdom), H. Wilkins (Southampton (Hampshire), United Kingdom), A. Glen (Southampton (Hampshire), United Kingdom), W. Walker (Southampton (Hampshire), United Kingdom), J. Lucas (Southampton (Hampshire), United Kingdom). Experience of measuring nasal nitric oxide (nNO) in a National Primary Ciliary Dyskinesia (PCD) Centre (2006-20). 2070
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Nasal nitric oxide (nNO) in paediatric primary ciliary dyskinesia (PCD) and in healthy children - On the lookout for optimal cut-off and reference range Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016
New portable nasal nitric oxide (nNO) analyser differentiates primary ciliary dyskinesia (PCD) from healthy individuals. Source: International Congress 2017 – Primary ciliary dyskinesia and air pollution Year: 2017
The use of exhaled nitric oxide (NO) to categorize asthma phenotype and treatment in children - Results from National Hospital of Pediatrics Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools Year: 2018
Utility and validity of NO Vario Analyser® equipment for the determination of nitric oxide in exhaled air (FeNO) Source: International Congress 2014 – Airway biomarkers Year: 2014
Detection of primary ciliary dyskinesia by hand-held tidal breathing nasal nitric oxide measurements in a tertiary referral population Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children Year: 2014
Normal values of exhaled nitric oxide at 50 mL/s – A revisit Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014
Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014
Alveolar nitric oxide (NO) in children born extremely preterm (EP) Source: International Congress 2014 – Respiratory physiology and sleep disordered breathing in children Year: 2014
Earlier use of fractional exhaled Nitric Oxide (FeNO) and challenge testing improves speed and accuracy of asthma diagnosis. MacLeod J, Respiratory Physiology, Bradshaw TA, Respiratory Medicine, Royal Infirmary of Edinburgh Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018
The Relationship between Fractional exhaled nitric oxide (FeNO) and Asthma Control and Asthma Severity in Asthmatic Adults in Vietnam Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018
Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
L-Arginine metabolism in airways of children with primary ciliary dyskinesia (PCD) or cystic fibrosis (CF) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Associations between fractional exhaled nitric oxide (FeNO), asthma, respiratory symptoms and self-reported allergies in female university students in Kobe, Japan Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015
Repeatability of FeNO measurements with an airway inflammation monitor using the 6 second (6s) and the 10 second (10s) exhalation modes in children 6 to 10 years of age with asthma Source: International Congress 2014 – Airway biomarkers Year: 2014
Positive relationship between offline exhaled nitric oxide and lung clearance index in pre-school wheezers Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014
Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation Source: International Congress 2014 – Asthma: clinical problems Year: 2014
Measurement of exhaled nitric oxide in children, 2001: E. Baraldi and J.C. de Jongste on behalf of the Task Force Source: Eur Respir J 2002; 20: 223-237 Year: 2002
Inducible nitric oxide synthase polymorphism in asthmatic patients Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014
Late Breaking Abstract - Management of asthma in pregnancy using fractional exhaled nitric oxide (FENO) to adjust inhaled corticosteroid (ICS) dose did not improve perinatal outcomes: the Breathing for Life Trial (BLT) Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016